{"entities": [{"EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "TradingSymbol": "EYEG", "EntityCentralIndexKey": "1372514", "db": 1, "Industry_SEC": "Pharmaceutical Preparations", "Industry_SEC_db": 2834, "Industry": "Pharmaceutical", "Industry_db": 37, "Region": "Massachusetts", "Region_db": 22, "SecurityExchangeName": "0", "SECurl": "0", "URL": "", "SEC_Update": "2021-11-11", "SEC_UpdateDateAndTime": null, "SecuritiesUpdate": "2021-06-03T00:00:00Z", "OpinionLastYear": null, "OpinionSecondLastYear": null, "OpinionThirdLastYear": null, "OpinionFourthLastYear": null, "ClockLastYear": 23.0, "ClockSecondLastYear": 14.0, "ClockThirdLastYear": 43.0, "ClockFourthLastYear": 0.0, "BridgeLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "BridgeSecondLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "BridgeThirdLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "BridgeFourthLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "Anomalies": "0", "AnomaliesRatio1": 30.05, "AnomaliesRatio2": 28.9, "AnomaliesRatio3": 74.47, "AnomaliesRatio4": 39.21, "AnomaliesRatio5": 32.64, "AnomaliesRatio6": 37.7, "NumberOfYearsAudited": 0, "CommonSharesIntrinsicValueLastYear": 6999500, "CommonSharesIntrinsicValueSecondLastYear": 6622414, "CommonSharesIntrinsicValueThirdLastYear": 8936226, "CommonSharesIntrinsicValueFourthLastYear": null, "MarketCapitalizationLastYear": 31088855, "MarketCapitalizationSecondLastYear": 46360085, "MarketCapitalizationThirdLastYear": 20581646, "MarketCapitalizationFourthLastYear": 18465263, "CommonShareIntrinsicValueLastYear": 0.99, "CommonShareIntrinsicValueSecondLastYear": 1.43, "CommonShareIntrinsicValueThirdLastYear": 0.2, "CommonShareIntrinsicValueFourthLastYear": null, "CommonSharePriceLastYear": 4.38, "CommonSharePriceSecondLastYear": 10.02, "CommonSharePriceThirdLastYear": 0.47, "CommonSharePriceFourthLastYear": 1.07, "CommonSharesOutstandingLastYear": 7097912, "CommonSharesOutstandingSecondLastYear": 4626755, "CommonSharesOutstandingThirdLastYear": 43790737, "CommonSharesOutstandingFourthLastYear": 17257255, "month_end": 12, "lastyear": "2020-12-31", "secondlastyear": "2019-12-31", "thirdlastyear": "2018-12-31", "fourthlastyear": "2017-12-31", "fifthlastyear": "2016-12-31", "sixthlastyear": "2015-12-31", "amendlastyear": "", "amendsecondlastyear": "", "amendthirdlastyear": "", "amendfourthlastyear": "", "amendfifthlastyear": "", "amendsixthlastyear": "", "accessionnumberlastyear": "0001104659-21-041515", "accessionnumbersecondlastyear": "0001104659-20-029162", "accessionnumberthirdlastyear": "0001144204-19-011634", "accessionnumberfourthlastyear": "0001144204-18-012542", "accessionnumberfifthlastyear": "0001144204-17-010635", "accessionnumbersixthlastyear": "0001144204-16-091485", "urlbalancesheetlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000110465921041515/R2.htm", "urlbalancesheetsecondlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000110465920029162/R2.htm", "urlbalancesheetthirdlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000114420419011634/R2.htm", "urlbalancesheetfourthlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000114420418012542/R2.htm", "urlbalancesheetfifthlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000114420417010635/R2.htm", "urlbalancesheetsixthlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000114420416091485/R2.htm", "urlincomestatementlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000110465921041515/R4.htm", "urlincomestatementsecondlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000110465920029162/R4.htm", "urlincomestatementthirdlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000114420419011634/R4.htm", "urlincomestatementfourthlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000114420418012542/R4.htm", "urlincomestatementfifthlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000114420417010635/R4.htm", "urlincomestatementsixthlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000114420416091485/R4.htm", "urlcomprehensiveincomelastyear": "", "urlcomprehensiveincomesecondlastyear": "", "urlcomprehensiveincomethirdlastyear": "", "urlcomprehensiveincomefourthlastyear": "", "urlcomprehensiveincomefifthlastyear": "", "urlcomprehensiveincomesixthlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000114420416091485/R5.htm", "urlshareholdersequitylastyear": "", "urlshareholdersequitysecondlastyear": "", "urlshareholdersequitythirdlastyear": "", "urlshareholdersequityfourthlastyear": "", "urlshareholdersequityfifthlastyear": "", "urlshareholdersequitysixthlastyear": "", "urlcashflowlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000110465921041515/R7.htm", "urlcashflowsecondlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000110465920029162/R7.htm", "urlcashflowthirdlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000114420419011634/R7.htm", "urlcashflowfourthlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000114420418012542/R7.htm", "urlcashflowfifthlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000114420417010635/R7.htm", "urlcashflowsixthlastyear": "https://www.sec.gov/Archives/edgar/data/1372514/000114420416091485/R8.htm", "ad1.db": 0, "ad1.AccessionNumber": "0001104659-21-041515", "ad1.AmendmentFlag": "", "ad1.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "ad1.Period": "lastyear", "ad1.PeriodEndDate": "2020-12-31", "ad1.TradingSymbol": "EYEG", "ad1.CurrentAssets": 1810149, "ad1.NonCurrentAssets": 13347410, "ad1.Assets": 0, "ad1.CurrentLiabilities": -1772327, "ad1.NonCurrentLiabilities": -6385691, "ad1.Liabilities": 0, "ad1.ShareholdersEquity": -6999541, "ad1.LiabilitiesAndShareholdersEquity": 0, "ad1.CurrentAssetsGL_i": "", "ad1.CurrentAssetsGL_ii": "", "ad1.CurrentAssetsGL_iii": "", "ad1.AnomalyCurrentAssets": 0, "ad1.AnomalyCurrentAssetsSEC": 0, "ad1.NonCurrentAssetsGL_i": "", "ad1.NonCurrentAssetsGL_ii": "", "ad1.NonCurrentAssetsGL_iii": "", "ad1.AnomalyNonCurrentAssets": 0, "ad1.AnomalyNonCurrentAssetsSEC": 0, "ad1.AnomalyAssets": 0, "ad1.CurrentLiabilitiesGL_i": "", "ad1.CurrentLiabilitiesGL_ii": "", "ad1.CurrentLiabilitiesGL_iii": "", "ad1.AnomalyCurrentLiabilities": 0, "ad1.AnomalyCurrentLiabilitiesSEC": 0, "ad1.NonCurrentLiabilitiesGL_i": "", "ad1.NonCurrentLiabilitiesGL_ii": "", "ad1.NonCurrentLiabilitiesGL_iii": "", "ad1.AnomalyNonCurrentLiabilities": -35625, "ad1.AnomalyNonCurrentLiabilitiesSEC": 0, "ad1.AnomalyLiabilities": 0, "ad1.AnomalyShareholdersEquity": 41, "ad1.ShareholdersEquityBalanceGL_i": "", "ad1.ShareholdersEquityBalanceGL_ii": "", "ad1.ShareholdersEquityBalanceGL_iii": "", "ad1.AnomalyShareholdersEquitySEC": 0, "ad1.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad1.Sales": 0, "ad1.CostOfSales": 0, "ad1.GrossMargin": -12059, "ad1.OperatingExpenses": 0, "ad1.OperatingIncome": 8212755, "ad1.IncomeBeforeTaxes": 8079885, "ad1.NetIncome": 8091940, "ad1.NetIncomeAttributableToNonControllingInterest": 0, "ad1.GrossMarginGL_i": "", "ad1.GrossMarginGL_ii": "", "ad1.GrossMarginGL_iii": "", "ad1.AnomalyGrossMargin": 0, "ad1.OperatingExpensesGL_i": "", "ad1.OperatingExpensesGL_ii": "", "ad1.OperatingExpensesGL_iii": "", "ad1.AnomalyOperatingExpenses": 0, "ad1.OperatingIncomeGL_i": "", "ad1.OperatingIncomeGL_ii": "", "ad1.OperatingIncomeGL_iii": "", "ad1.AnomalyOperatingIncome": 0, "ad1.IncomeBeforeTaxesGL_i": "", "ad1.IncomeBeforeTaxesGL_ii": "", "ad1.IncomeBeforeTaxesGL_iii": "", "ad1.AnomalyIncomeBeforeTaxes": 0, "ad1.NetIncomeGL_i": "", "ad1.NetIncomeGL_ii": "", "ad1.NetIncomeGL_iii": "", "ad1.AnomalyNetIncome": 0, "ad1.OtherComprehensiveIncome": 140267, "ad1.ComprehensiveIncome": 0, "ad1.OtherComprehensiveIncomeGL_i": "", "ad1.OtherComprehensiveIncomeGL_ii": "", "ad1.OtherComprehensiveIncomeGL_iii": "", "ad1.AnomalyOtherComprehensiveIncome": 8091940, "ad1.AnomalyComprehensiveIncome": 0, "ad1.ShareholdersEquityBeginning": 0, "ad1.ConvertibleDebt": 0, "ad1.CommonShares": 0, "ad1.PreferredShares": 0, "ad1.RetainedEarnings": 0, "ad1.AccumulatedOtherComprehensiveIncome": 0, "ad1.TreasuryShares": 0, "ad1.EmployeeBenefitTrust": 0, "ad1.NonControllingInterests": 0, "ad1.AnomalyConvertibleDebt": 0, "ad1.AnomalyCommonShares": 4107980, "ad1.AnomalyPreferredShares": 0, "ad1.AnomalyRetainedEarnings": 0, "ad1.AnomalyAccumulatedOtherComprehensiveIncome": -8232207, "ad1.AnomalyTreasuryShares": 0, "ad1.AnomalyEmployeeBenefitTrust": 0, "ad1.AnomalyNonControllingInterests": 0, "ad1.ShareholdersEquityGL_i": "", "ad1.ShareholdersEquityGL_ii": "", "ad1.ShareholdersEquityGL_iii": "", "ad1.OperatingActivities": 0, "ad1.InvestingActivities": 0, "ad1.FinancingActivities": 0, "ad1.IncreaseDecreaseInCash": 0, "ad1.CashFlowCashExplainedDifference": 45000, "ad1.OperatingActivitiesGL_i": "", "ad1.OperatingActivitiesGL_ii": "", "ad1.OperatingActivitiesGL_iii": "", "ad1.AnomalyOperatingActivities": 0, "ad1.AnomalyOperatingActivitiesSEC": 0, "ad1.InvestingActivitiesGL_i": "", "ad1.InvestingActivitiesGL_ii": "", "ad1.InvestingActivitiesGL_iii": "", "ad1.AnomalyInvestingActivities": 113717, "ad1.AnomalyInvestingActivitiesSEC": 0, "ad1.FinancingActivitiesGL_i": "", "ad1.FinancingActivitiesGL_ii": "", "ad1.FinancingActivitiesGL_iii": "", "ad1.AnomalyFinancingActivities": -4719313, "ad1.AnomalyFinancingActivitiesSEC": 0, "ad1.TargetWorkingCapital": 1.2, "ad1.ReinvestmentOfMaintenance": 20077, "ad1.NormalizedDividendPaymentToNonControllingInterests": 0, "ad1.NormalizedDividendPaymentToPreferredShareholders": 0, "ad1.TheoricalInterestRate": 0.035, "ad1.TheoricalTaxRate": 0.15, "ad1.CapitalizationRateFloor": 0.021, "ad2.db": 0, "ad2.AccessionNumber": "0001104659-20-029162", "ad2.AmendmentFlag": "", "ad2.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "ad2.Period": "secondlastyear", "ad2.PeriodEndDate": "2019-12-31", "ad2.TradingSymbol": "EYEG", "ad2.CurrentAssets": 4324305, "ad2.NonCurrentAssets": 5788209, "ad2.Assets": 0, "ad2.CurrentLiabilities": -1414695, "ad2.NonCurrentLiabilities": -2075364, "ad2.Liabilities": 0, "ad2.ShareholdersEquity": -6622455, "ad2.LiabilitiesAndShareholdersEquity": 0, "ad2.CurrentAssetsGL_i": "", "ad2.CurrentAssetsGL_ii": "", "ad2.CurrentAssetsGL_iii": "", "ad2.AnomalyCurrentAssets": 0, "ad2.AnomalyCurrentAssetsSEC": 0, "ad2.NonCurrentAssetsGL_i": "", "ad2.NonCurrentAssetsGL_ii": "", "ad2.NonCurrentAssetsGL_iii": "", "ad2.AnomalyNonCurrentAssets": 0, "ad2.AnomalyNonCurrentAssetsSEC": 0, "ad2.AnomalyAssets": 0, "ad2.CurrentLiabilitiesGL_i": "", "ad2.CurrentLiabilitiesGL_ii": "", "ad2.CurrentLiabilitiesGL_iii": "", "ad2.AnomalyCurrentLiabilities": 0, "ad2.AnomalyCurrentLiabilitiesSEC": 0, "ad2.NonCurrentLiabilitiesGL_i": "", "ad2.NonCurrentLiabilitiesGL_ii": "", "ad2.NonCurrentLiabilitiesGL_iii": "", "ad2.AnomalyNonCurrentLiabilities": 0, "ad2.AnomalyNonCurrentLiabilitiesSEC": 0, "ad2.AnomalyLiabilities": 0, "ad2.AnomalyShareholdersEquity": 41, "ad2.ShareholdersEquityBalanceGL_i": "", "ad2.ShareholdersEquityBalanceGL_ii": "", "ad2.ShareholdersEquityBalanceGL_iii": "", "ad2.AnomalyShareholdersEquitySEC": 0, "ad2.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad2.Sales": 0, "ad2.CostOfSales": 0, "ad2.GrossMargin": -2686000, "ad2.OperatingExpenses": 0, "ad2.OperatingIncome": -3669673, "ad2.IncomeBeforeTaxes": 7001300, "ad2.NetIncome": 7096696, "ad2.NetIncomeAttributableToNonControllingInterest": 0, "ad2.GrossMarginGL_i": "", "ad2.GrossMarginGL_ii": "", "ad2.GrossMarginGL_iii": "", "ad2.AnomalyGrossMargin": 0, "ad2.OperatingExpensesGL_i": "", "ad2.OperatingExpensesGL_ii": "", "ad2.OperatingExpensesGL_iii": "", "ad2.AnomalyOperatingExpenses": 0, "ad2.OperatingIncomeGL_i": "", "ad2.OperatingIncomeGL_ii": "", "ad2.OperatingIncomeGL_iii": "", "ad2.AnomalyOperatingIncome": 0, "ad2.IncomeBeforeTaxesGL_i": "", "ad2.IncomeBeforeTaxesGL_ii": "", "ad2.IncomeBeforeTaxesGL_iii": "", "ad2.AnomalyIncomeBeforeTaxes": 0, "ad2.NetIncomeGL_i": "", "ad2.NetIncomeGL_ii": "", "ad2.NetIncomeGL_iii": "", "ad2.AnomalyNetIncome": 0, "ad2.OtherComprehensiveIncome": -5134, "ad2.ComprehensiveIncome": 0, "ad2.OtherComprehensiveIncomeGL_i": "", "ad2.OtherComprehensiveIncomeGL_ii": "", "ad2.OtherComprehensiveIncomeGL_iii": "", "ad2.AnomalyOtherComprehensiveIncome": 7096696, "ad2.AnomalyComprehensiveIncome": 0, "ad2.ShareholdersEquityBeginning": 0, "ad2.ConvertibleDebt": 0, "ad2.CommonShares": 0, "ad2.PreferredShares": 0, "ad2.RetainedEarnings": 0, "ad2.AccumulatedOtherComprehensiveIncome": 0, "ad2.TreasuryShares": 0, "ad2.EmployeeBenefitTrust": 0, "ad2.NonControllingInterests": 0, "ad2.AnomalyConvertibleDebt": 0, "ad2.AnomalyCommonShares": 4777750, "ad2.AnomalyPreferredShares": 0, "ad2.AnomalyRetainedEarnings": 0, "ad2.AnomalyAccumulatedOtherComprehensiveIncome": -7091562, "ad2.AnomalyTreasuryShares": 0, "ad2.AnomalyEmployeeBenefitTrust": 0, "ad2.AnomalyNonControllingInterests": 0, "ad2.ShareholdersEquityGL_i": "", "ad2.ShareholdersEquityGL_ii": "", "ad2.ShareholdersEquityGL_iii": "", "ad2.OperatingActivities": 0, "ad2.InvestingActivities": 0, "ad2.FinancingActivities": 0, "ad2.IncreaseDecreaseInCash": 0, "ad2.CashFlowCashExplainedDifference": 45000, "ad2.OperatingActivitiesGL_i": "", "ad2.OperatingActivitiesGL_ii": "", "ad2.OperatingActivitiesGL_iii": "", "ad2.AnomalyOperatingActivities": 0, "ad2.AnomalyOperatingActivitiesSEC": 0, "ad2.InvestingActivitiesGL_i": "", "ad2.InvestingActivitiesGL_ii": "", "ad2.InvestingActivitiesGL_iii": "", "ad2.AnomalyInvestingActivities": 0, "ad2.AnomalyInvestingActivitiesSEC": 0, "ad2.FinancingActivitiesGL_i": "", "ad2.FinancingActivitiesGL_ii": "", "ad2.FinancingActivitiesGL_iii": "", "ad2.AnomalyFinancingActivities": 0, "ad2.AnomalyFinancingActivitiesSEC": 0, "ad2.TargetWorkingCapital": 1.2, "ad2.ReinvestmentOfMaintenance": 0, "ad2.NormalizedDividendPaymentToNonControllingInterests": 0, "ad2.NormalizedDividendPaymentToPreferredShareholders": 0, "ad2.TheoricalInterestRate": 0.035, "ad2.TheoricalTaxRate": 0.15, "ad2.CapitalizationRateFloor": 0.021, "ad3.db": 0, "ad3.AccessionNumber": "0001144204-19-011634", "ad3.AmendmentFlag": "", "ad3.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "ad3.Period": "thirdlastyear", "ad3.PeriodEndDate": "2018-12-31", "ad3.TradingSymbol": "EYEG", "ad3.CurrentAssets": 8478433, "ad3.NonCurrentAssets": 5802184, "ad3.Assets": 0, "ad3.CurrentLiabilities": -3864382, "ad3.NonCurrentLiabilities": -1479968, "ad3.Liabilities": 0, "ad3.ShareholdersEquity": -8936267, "ad3.LiabilitiesAndShareholdersEquity": 0, "ad3.CurrentAssetsGL_i": "", "ad3.CurrentAssetsGL_ii": "", "ad3.CurrentAssetsGL_iii": "", "ad3.AnomalyCurrentAssets": 0, "ad3.AnomalyCurrentAssetsSEC": 0, "ad3.NonCurrentAssetsGL_i": "", "ad3.NonCurrentAssetsGL_ii": "", "ad3.NonCurrentAssetsGL_iii": "", "ad3.AnomalyNonCurrentAssets": 0, "ad3.AnomalyNonCurrentAssetsSEC": 0, "ad3.AnomalyAssets": 0, "ad3.CurrentLiabilitiesGL_i": "", "ad3.CurrentLiabilitiesGL_ii": "", "ad3.CurrentLiabilitiesGL_iii": "", "ad3.AnomalyCurrentLiabilities": 0, "ad3.AnomalyCurrentLiabilitiesSEC": 0, "ad3.NonCurrentLiabilitiesGL_i": "", "ad3.NonCurrentLiabilitiesGL_ii": "", "ad3.NonCurrentLiabilitiesGL_iii": "", "ad3.AnomalyNonCurrentLiabilities": 0, "ad3.AnomalyNonCurrentLiabilitiesSEC": 0, "ad3.AnomalyLiabilities": 0, "ad3.AnomalyShareholdersEquity": 41, "ad3.ShareholdersEquityBalanceGL_i": "", "ad3.ShareholdersEquityBalanceGL_ii": "", "ad3.ShareholdersEquityBalanceGL_iii": "", "ad3.AnomalyShareholdersEquitySEC": 0, "ad3.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad3.Sales": 0, "ad3.CostOfSales": 0, "ad3.GrossMargin": -1652520, "ad3.OperatingExpenses": 0, "ad3.OperatingIncome": 10844701, "ad3.IncomeBeforeTaxes": 10725378, "ad3.NetIncome": 10811423, "ad3.NetIncomeAttributableToNonControllingInterest": 0, "ad3.GrossMarginGL_i": "", "ad3.GrossMarginGL_ii": "", "ad3.GrossMarginGL_iii": "", "ad3.AnomalyGrossMargin": 0, "ad3.OperatingExpensesGL_i": "", "ad3.OperatingExpensesGL_ii": "", "ad3.OperatingExpensesGL_iii": "", "ad3.AnomalyOperatingExpenses": 0, "ad3.OperatingIncomeGL_i": "", "ad3.OperatingIncomeGL_ii": "", "ad3.OperatingIncomeGL_iii": "", "ad3.AnomalyOperatingIncome": 0, "ad3.IncomeBeforeTaxesGL_i": "", "ad3.IncomeBeforeTaxesGL_ii": "", "ad3.IncomeBeforeTaxesGL_iii": "", "ad3.AnomalyIncomeBeforeTaxes": 0, "ad3.NetIncomeGL_i": "", "ad3.NetIncomeGL_ii": "", "ad3.NetIncomeGL_iii": "", "ad3.AnomalyNetIncome": 0, "ad3.OtherComprehensiveIncome": -6858, "ad3.ComprehensiveIncome": 0, "ad3.OtherComprehensiveIncomeGL_i": "", "ad3.OtherComprehensiveIncomeGL_ii": "", "ad3.OtherComprehensiveIncomeGL_iii": "", "ad3.AnomalyOtherComprehensiveIncome": 10811423, "ad3.AnomalyComprehensiveIncome": 0, "ad3.ShareholdersEquityBeginning": 0, "ad3.ConvertibleDebt": 0, "ad3.CommonShares": 0, "ad3.PreferredShares": 0, "ad3.RetainedEarnings": 0, "ad3.AccumulatedOtherComprehensiveIncome": 0, "ad3.TreasuryShares": 0, "ad3.EmployeeBenefitTrust": 0, "ad3.NonControllingInterests": 0, "ad3.AnomalyConvertibleDebt": 0, "ad3.AnomalyCommonShares": 821220, "ad3.AnomalyPreferredShares": 0, "ad3.AnomalyRetainedEarnings": 18955760, "ad3.AnomalyAccumulatedOtherComprehensiveIncome": -10804565, "ad3.AnomalyTreasuryShares": 0, "ad3.AnomalyEmployeeBenefitTrust": 0, "ad3.AnomalyNonControllingInterests": 0, "ad3.ShareholdersEquityGL_i": "", "ad3.ShareholdersEquityGL_ii": "", "ad3.ShareholdersEquityGL_iii": "", "ad3.OperatingActivities": 0, "ad3.InvestingActivities": 0, "ad3.FinancingActivities": 0, "ad3.IncreaseDecreaseInCash": 0, "ad3.CashFlowCashExplainedDifference": 45000, "ad3.OperatingActivitiesGL_i": "", "ad3.OperatingActivitiesGL_ii": "", "ad3.OperatingActivitiesGL_iii": "", "ad3.AnomalyOperatingActivities": 0, "ad3.AnomalyOperatingActivitiesSEC": 0, "ad3.InvestingActivitiesGL_i": "", "ad3.InvestingActivitiesGL_ii": "", "ad3.InvestingActivitiesGL_iii": "", "ad3.AnomalyInvestingActivities": 250000, "ad3.AnomalyInvestingActivitiesSEC": 0, "ad3.FinancingActivitiesGL_i": "", "ad3.FinancingActivitiesGL_ii": "", "ad3.FinancingActivitiesGL_iii": "", "ad3.AnomalyFinancingActivities": -1196043, "ad3.AnomalyFinancingActivitiesSEC": 0, "ad3.TargetWorkingCapital": 1.2, "ad3.ReinvestmentOfMaintenance": 20000, "ad3.NormalizedDividendPaymentToNonControllingInterests": 0, "ad3.NormalizedDividendPaymentToPreferredShareholders": 0, "ad3.TheoricalInterestRate": 0.035, "ad3.TheoricalTaxRate": 0.15, "ad3.CapitalizationRateFloor": 0.021, "ad4.db": 0, "ad4.AccessionNumber": "0001144204-18-012542", "ad4.AmendmentFlag": "", "ad4.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "ad4.Period": "fourthlastyear", "ad4.PeriodEndDate": "2017-12-31", "ad4.TradingSymbol": "EYEG", "ad4.CurrentAssets": 8459305, "ad4.NonCurrentAssets": 5846087, "ad4.Assets": 0, "ad4.CurrentLiabilities": -14833536, "ad4.NonCurrentLiabilities": -1398778, "ad4.Liabilities": 0, "ad4.ShareholdersEquity": 1926922, "ad4.LiabilitiesAndShareholdersEquity": 0, "ad4.CurrentAssetsGL_i": "", "ad4.CurrentAssetsGL_ii": "", "ad4.CurrentAssetsGL_iii": "", "ad4.AnomalyCurrentAssets": 0, "ad4.AnomalyCurrentAssetsSEC": 0, "ad4.NonCurrentAssetsGL_i": "", "ad4.NonCurrentAssetsGL_ii": "", "ad4.NonCurrentAssetsGL_iii": "", "ad4.AnomalyNonCurrentAssets": 0, "ad4.AnomalyNonCurrentAssetsSEC": 0, "ad4.AnomalyAssets": 0, "ad4.CurrentLiabilitiesGL_i": "", "ad4.CurrentLiabilitiesGL_ii": "", "ad4.CurrentLiabilitiesGL_iii": "", "ad4.AnomalyCurrentLiabilities": 0, "ad4.AnomalyCurrentLiabilitiesSEC": 0, "ad4.NonCurrentLiabilitiesGL_i": "", "ad4.NonCurrentLiabilitiesGL_ii": "", "ad4.NonCurrentLiabilitiesGL_iii": "", "ad4.AnomalyNonCurrentLiabilities": 0, "ad4.AnomalyNonCurrentLiabilitiesSEC": 0, "ad4.AnomalyLiabilities": 0, "ad4.AnomalyShareholdersEquity": 6, "ad4.ShareholdersEquityBalanceGL_i": "", "ad4.ShareholdersEquityBalanceGL_ii": "", "ad4.ShareholdersEquityBalanceGL_iii": "", "ad4.AnomalyShareholdersEquitySEC": 0, "ad4.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad4.Sales": 0, "ad4.CostOfSales": 0, "ad4.GrossMargin": -407518, "ad4.OperatingExpenses": 0, "ad4.OperatingIncome": 14559239, "ad4.IncomeBeforeTaxes": 14559890, "ad4.NetIncome": 13217917, "ad4.NetIncomeAttributableToNonControllingInterest": 0, "ad4.GrossMarginGL_i": "", "ad4.GrossMarginGL_ii": "", "ad4.GrossMarginGL_iii": "", "ad4.AnomalyGrossMargin": 0, "ad4.OperatingExpensesGL_i": "", "ad4.OperatingExpensesGL_ii": "", "ad4.OperatingExpensesGL_iii": "", "ad4.AnomalyOperatingExpenses": 0, "ad4.OperatingIncomeGL_i": "", "ad4.OperatingIncomeGL_ii": "", "ad4.OperatingIncomeGL_iii": "", "ad4.AnomalyOperatingIncome": 0, "ad4.IncomeBeforeTaxesGL_i": "", "ad4.IncomeBeforeTaxesGL_ii": "", "ad4.IncomeBeforeTaxesGL_iii": "", "ad4.AnomalyIncomeBeforeTaxes": 0, "ad4.NetIncomeGL_i": "", "ad4.NetIncomeGL_ii": "", "ad4.NetIncomeGL_iii": "", "ad4.AnomalyNetIncome": 0, "ad4.OtherComprehensiveIncome": -7286, "ad4.ComprehensiveIncome": 0, "ad4.OtherComprehensiveIncomeGL_i": "", "ad4.OtherComprehensiveIncomeGL_ii": "", "ad4.OtherComprehensiveIncomeGL_iii": "", "ad4.AnomalyOtherComprehensiveIncome": 13217917, "ad4.AnomalyComprehensiveIncome": 0, "ad4.ShareholdersEquityBeginning": 0, "ad4.ConvertibleDebt": 0, "ad4.CommonShares": 0, "ad4.PreferredShares": 0, "ad4.RetainedEarnings": 0, "ad4.AccumulatedOtherComprehensiveIncome": 0, "ad4.TreasuryShares": 0, "ad4.EmployeeBenefitTrust": 0, "ad4.NonControllingInterests": 0, "ad4.AnomalyConvertibleDebt": 0, "ad4.AnomalyCommonShares": 2888520, "ad4.AnomalyPreferredShares": 0, "ad4.AnomalyRetainedEarnings": 0, "ad4.AnomalyAccumulatedOtherComprehensiveIncome": -13210631, "ad4.AnomalyTreasuryShares": 0, "ad4.AnomalyEmployeeBenefitTrust": 0, "ad4.AnomalyNonControllingInterests": 0, "ad4.ShareholdersEquityGL_i": "", "ad4.ShareholdersEquityGL_ii": "", "ad4.ShareholdersEquityGL_iii": "", "ad4.OperatingActivities": 0, "ad4.InvestingActivities": 0, "ad4.FinancingActivities": 0, "ad4.IncreaseDecreaseInCash": 0, "ad4.CashFlowCashExplainedDifference": 45000, "ad4.OperatingActivitiesGL_i": "", "ad4.OperatingActivitiesGL_ii": "", "ad4.OperatingActivitiesGL_iii": "", "ad4.AnomalyOperatingActivities": 0, "ad4.AnomalyOperatingActivitiesSEC": 0, "ad4.InvestingActivitiesGL_i": "", "ad4.InvestingActivitiesGL_ii": "", "ad4.InvestingActivitiesGL_iii": "", "ad4.AnomalyInvestingActivities": 0, "ad4.AnomalyInvestingActivitiesSEC": 0, "ad4.FinancingActivitiesGL_i": "", "ad4.FinancingActivitiesGL_ii": "", "ad4.FinancingActivitiesGL_iii": "", "ad4.AnomalyFinancingActivities": -10576538, "ad4.AnomalyFinancingActivitiesSEC": 0, "ad4.TargetWorkingCapital": 1.2, "ad4.ReinvestmentOfMaintenance": 36999, "ad4.NormalizedDividendPaymentToNonControllingInterests": 0, "ad4.NormalizedDividendPaymentToPreferredShareholders": 0, "ad4.TheoricalInterestRate": 0.035, "ad4.TheoricalTaxRate": 0.15, "ad4.CapitalizationRateFloor": 0.021, "ad5.db": 0, "ad5.AccessionNumber": "0001144204-17-010635", "ad5.AmendmentFlag": "", "ad5.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "ad5.Period": "fifthlastyear", "ad5.PeriodEndDate": "2016-12-31", "ad5.TradingSymbol": "EYEG", "ad5.CurrentAssets": 4154038, "ad5.NonCurrentAssets": 5576564, "ad5.Assets": 0, "ad5.CurrentLiabilities": -7308058, "ad5.NonCurrentLiabilities": -2751965, "ad5.Liabilities": 0, "ad5.ShareholdersEquity": 329421, "ad5.LiabilitiesAndShareholdersEquity": 0, "ad5.CurrentAssetsGL_i": "", "ad5.CurrentAssetsGL_ii": "", "ad5.CurrentAssetsGL_iii": "", "ad5.AnomalyCurrentAssets": 0, "ad5.AnomalyCurrentAssetsSEC": 0, "ad5.NonCurrentAssetsGL_i": "", "ad5.NonCurrentAssetsGL_ii": "", "ad5.NonCurrentAssetsGL_iii": "", "ad5.AnomalyNonCurrentAssets": 0, "ad5.AnomalyNonCurrentAssetsSEC": 0, "ad5.AnomalyAssets": 0, "ad5.CurrentLiabilitiesGL_i": "", "ad5.CurrentLiabilitiesGL_ii": "", "ad5.CurrentLiabilitiesGL_iii": "", "ad5.AnomalyCurrentLiabilities": 0, "ad5.AnomalyCurrentLiabilitiesSEC": 0, "ad5.NonCurrentLiabilitiesGL_i": "", "ad5.NonCurrentLiabilitiesGL_ii": "", "ad5.NonCurrentLiabilitiesGL_iii": "", "ad5.AnomalyNonCurrentLiabilities": 0, "ad5.AnomalyNonCurrentLiabilitiesSEC": 0, "ad5.AnomalyLiabilities": 0, "ad5.AnomalyShareholdersEquity": -58824, "ad5.ShareholdersEquityBalanceGL_i": "", "ad5.ShareholdersEquityBalanceGL_ii": "", "ad5.ShareholdersEquityBalanceGL_iii": "", "ad5.AnomalyShareholdersEquitySEC": 0, "ad5.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad5.Sales": 0, "ad5.CostOfSales": 0, "ad5.GrossMargin": 0, "ad5.OperatingExpenses": 0, "ad5.OperatingIncome": 0, "ad5.IncomeBeforeTaxes": 0, "ad5.NetIncome": 13343437, "ad5.NetIncomeAttributableToNonControllingInterest": 0, "ad5.GrossMarginGL_i": "", "ad5.GrossMarginGL_ii": "", "ad5.GrossMarginGL_iii": "", "ad5.AnomalyGrossMargin": 0, "ad5.OperatingExpensesGL_i": "", "ad5.OperatingExpensesGL_ii": "", "ad5.OperatingExpensesGL_iii": "", "ad5.AnomalyOperatingExpenses": 0, "ad5.OperatingIncomeGL_i": "", "ad5.OperatingIncomeGL_ii": "", "ad5.OperatingIncomeGL_iii": "", "ad5.AnomalyOperatingIncome": 0, "ad5.IncomeBeforeTaxesGL_i": "", "ad5.IncomeBeforeTaxesGL_ii": "", "ad5.IncomeBeforeTaxesGL_iii": "", "ad5.AnomalyIncomeBeforeTaxes": 0, "ad5.NetIncomeGL_i": "", "ad5.NetIncomeGL_ii": "", "ad5.NetIncomeGL_iii": "", "ad5.AnomalyNetIncome": -13343437, "ad5.OtherComprehensiveIncome": 0, "ad5.ComprehensiveIncome": 0, "ad5.OtherComprehensiveIncomeGL_i": "", "ad5.OtherComprehensiveIncomeGL_ii": "", "ad5.OtherComprehensiveIncomeGL_iii": "", "ad5.AnomalyOtherComprehensiveIncome": 13343437, "ad5.AnomalyComprehensiveIncome": 0, "ad5.ShareholdersEquityBeginning": 0, "ad5.ConvertibleDebt": 0, "ad5.CommonShares": 0, "ad5.PreferredShares": 0, "ad5.RetainedEarnings": 0, "ad5.AccumulatedOtherComprehensiveIncome": 0, "ad5.TreasuryShares": 0, "ad5.EmployeeBenefitTrust": 0, "ad5.NonControllingInterests": 0, "ad5.AnomalyConvertibleDebt": 0, "ad5.AnomalyCommonShares": 0, "ad5.AnomalyPreferredShares": 0, "ad5.AnomalyRetainedEarnings": 0, "ad5.AnomalyAccumulatedOtherComprehensiveIncome": -13343437, "ad5.AnomalyTreasuryShares": 0, "ad5.AnomalyEmployeeBenefitTrust": 0, "ad5.AnomalyNonControllingInterests": 0, "ad5.ShareholdersEquityGL_i": "", "ad5.ShareholdersEquityGL_ii": "", "ad5.ShareholdersEquityGL_iii": "", "ad5.OperatingActivities": 0, "ad5.InvestingActivities": 0, "ad5.FinancingActivities": 0, "ad5.IncreaseDecreaseInCash": 0, "ad5.CashFlowCashExplainedDifference": 0, "ad5.OperatingActivitiesGL_i": "", "ad5.OperatingActivitiesGL_ii": "", "ad5.OperatingActivitiesGL_iii": "", "ad5.AnomalyOperatingActivities": 0, "ad5.AnomalyOperatingActivitiesSEC": 0, "ad5.InvestingActivitiesGL_i": "", "ad5.InvestingActivitiesGL_ii": "", "ad5.InvestingActivitiesGL_iii": "", "ad5.AnomalyInvestingActivities": 0, "ad5.AnomalyInvestingActivitiesSEC": 0, "ad5.FinancingActivitiesGL_i": "", "ad5.FinancingActivitiesGL_ii": "", "ad5.FinancingActivitiesGL_iii": "", "ad5.AnomalyFinancingActivities": 2863, "ad5.AnomalyFinancingActivitiesSEC": 0, "ad5.TargetWorkingCapital": 1.2, "ad5.ReinvestmentOfMaintenance": 11000, "ad5.NormalizedDividendPaymentToNonControllingInterests": 0, "ad5.NormalizedDividendPaymentToPreferredShareholders": 0, "ad5.TheoricalInterestRate": 0.035, "ad5.TheoricalTaxRate": 0.0, "ad5.CapitalizationRateFloor": 0.021, "ad6.db": 0, "ad6.AccessionNumber": "0001144204-16-091485", "ad6.AmendmentFlag": "", "ad6.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "ad6.Period": "sixthlastyear", "ad6.PeriodEndDate": "2015-12-31", "ad6.TradingSymbol": "EYEG", "ad6.CurrentAssets": 9449114, "ad6.NonCurrentAssets": 58587, "ad6.Assets": 0, "ad6.CurrentLiabilities": -3420935, "ad6.NonCurrentLiabilities": 9507701, "ad6.Liabilities": 0, "ad6.ShareholdersEquity": -6086766, "ad6.LiabilitiesAndShareholdersEquity": 0, "ad6.CurrentAssetsGL_i": "", "ad6.CurrentAssetsGL_ii": "", "ad6.CurrentAssetsGL_iii": "", "ad6.AnomalyCurrentAssets": 0, "ad6.AnomalyCurrentAssetsSEC": 0, "ad6.NonCurrentAssetsGL_i": "", "ad6.NonCurrentAssetsGL_ii": "", "ad6.NonCurrentAssetsGL_iii": "", "ad6.AnomalyNonCurrentAssets": 0, "ad6.AnomalyNonCurrentAssetsSEC": 0, "ad6.AnomalyAssets": 0, "ad6.CurrentLiabilitiesGL_i": "", "ad6.CurrentLiabilitiesGL_ii": "", "ad6.CurrentLiabilitiesGL_iii": "", "ad6.AnomalyCurrentLiabilities": 0, "ad6.AnomalyCurrentLiabilitiesSEC": 0, "ad6.NonCurrentLiabilitiesGL_i": "", "ad6.NonCurrentLiabilitiesGL_ii": "", "ad6.NonCurrentLiabilitiesGL_iii": "", "ad6.AnomalyNonCurrentLiabilities": 9507701, "ad6.AnomalyNonCurrentLiabilitiesSEC": 0, "ad6.AnomalyLiabilities": 0, "ad6.AnomalyShareholdersEquity": 5971978, "ad6.ShareholdersEquityBalanceGL_i": "", "ad6.ShareholdersEquityBalanceGL_ii": "", "ad6.ShareholdersEquityBalanceGL_iii": "", "ad6.AnomalyShareholdersEquitySEC": 0, "ad6.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad6.Sales": 0, "ad6.CostOfSales": 0, "ad6.GrossMargin": 0, "ad6.OperatingExpenses": 0, "ad6.OperatingIncome": 0, "ad6.IncomeBeforeTaxes": 0, "ad6.NetIncome": 8387972, "ad6.NetIncomeAttributableToNonControllingInterest": 0, "ad6.GrossMarginGL_i": "", "ad6.GrossMarginGL_ii": "", "ad6.GrossMarginGL_iii": "", "ad6.AnomalyGrossMargin": 0, "ad6.OperatingExpensesGL_i": "", "ad6.OperatingExpensesGL_ii": "", "ad6.OperatingExpensesGL_iii": "", "ad6.AnomalyOperatingExpenses": 0, "ad6.OperatingIncomeGL_i": "", "ad6.OperatingIncomeGL_ii": "", "ad6.OperatingIncomeGL_iii": "", "ad6.AnomalyOperatingIncome": 0, "ad6.IncomeBeforeTaxesGL_i": "", "ad6.IncomeBeforeTaxesGL_ii": "", "ad6.IncomeBeforeTaxesGL_iii": "", "ad6.AnomalyIncomeBeforeTaxes": 0, "ad6.NetIncomeGL_i": "", "ad6.NetIncomeGL_ii": "", "ad6.NetIncomeGL_iii": "", "ad6.AnomalyNetIncome": -8387972, "ad6.OtherComprehensiveIncome": -91211, "ad6.ComprehensiveIncome": 0, "ad6.OtherComprehensiveIncomeGL_i": "", "ad6.OtherComprehensiveIncomeGL_ii": "", "ad6.OtherComprehensiveIncomeGL_iii": "", "ad6.AnomalyOtherComprehensiveIncome": 8296761, "ad6.AnomalyComprehensiveIncome": 0, "ad6.ShareholdersEquityBeginning": 0, "ad6.ConvertibleDebt": 0, "ad6.CommonShares": 0, "ad6.PreferredShares": 0, "ad6.RetainedEarnings": 0, "ad6.AccumulatedOtherComprehensiveIncome": 0, "ad6.TreasuryShares": 0, "ad6.EmployeeBenefitTrust": 0, "ad6.NonControllingInterests": 0, "ad6.AnomalyConvertibleDebt": 0, "ad6.AnomalyCommonShares": 0, "ad6.AnomalyPreferredShares": 0, "ad6.AnomalyRetainedEarnings": 0, "ad6.AnomalyAccumulatedOtherComprehensiveIncome": -8296761, "ad6.AnomalyTreasuryShares": 0, "ad6.AnomalyEmployeeBenefitTrust": 0, "ad6.AnomalyNonControllingInterests": 0, "ad6.ShareholdersEquityGL_i": "", "ad6.ShareholdersEquityGL_ii": "", "ad6.ShareholdersEquityGL_iii": "", "ad6.OperatingActivities": 0, "ad6.InvestingActivities": 0, "ad6.FinancingActivities": 0, "ad6.IncreaseDecreaseInCash": 0, "ad6.CashFlowCashExplainedDifference": 0, "ad6.OperatingActivitiesGL_i": "", "ad6.OperatingActivitiesGL_ii": "", "ad6.OperatingActivitiesGL_iii": "", "ad6.AnomalyOperatingActivities": 0, "ad6.AnomalyOperatingActivitiesSEC": 0, "ad6.InvestingActivitiesGL_i": "", "ad6.InvestingActivitiesGL_ii": "", "ad6.InvestingActivitiesGL_iii": "", "ad6.AnomalyInvestingActivities": 0, "ad6.AnomalyInvestingActivitiesSEC": 0, "ad6.FinancingActivitiesGL_i": "", "ad6.FinancingActivitiesGL_ii": "", "ad6.FinancingActivitiesGL_iii": "", "ad6.AnomalyFinancingActivities": 32628, "ad6.AnomalyFinancingActivitiesSEC": 0, "ad6.TargetWorkingCapital": 1.2, "ad6.ReinvestmentOfMaintenance": 0, "ad6.NormalizedDividendPaymentToNonControllingInterests": 0, "ad6.NormalizedDividendPaymentToPreferredShareholders": 0, "ad6.TheoricalInterestRate": 0.035, "ad6.TheoricalTaxRate": 0.0, "ad6.CapitalizationRateFloor": 0.021, "cf1.AccessionNumber": "0001104659-21-041515", "cf1.AmendmentFlag": "", "cf1.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "cf1.Period": "lastyear", "cf1.PeriodEndDate": "2020-12-31", "cf1.TradingSymbol": "EYEG", "cf1.CashBeginningBalance": 3821712, "cf1.EffectOfExchangeRateOnCash": -26931, "cf1.DepreciationDepletionAndAmortization": 33399, "cf1.GainRelatedToDisposalOrSale": 0, "cf1.RestructuringAndOtherSpecialCharges": 0, "cf1.AccruedEmployeeCompensation": 0, "cf1.ShareBasedCompensation": 723856, "cf1.IncreaseDecreaseInIncomeTaxExpenseBenefit": 12055, "cf1.OtherNonCashIncomeExpense": 0, "cf1.IncreaseDecreaseInAccountsReceivable": -18957, "cf1.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": 12877, "cf1.IncreaseDecreaseInInventories": 0, "cf1.IncreaseDecreaseInOtherReceivables": 0, "cf1.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": -7375, "cf1.IncreaseDecreaseInContractWithCustomerLiability": 0, "cf1.IncreaseDecreaseInRetirementBenefits": 0, "cf1.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf1.IncreaseDecreaseOperatingLeaseCurrent": -166822, "cf1.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf1.IncreaseDecreaseInOtherOperatingActivities": 185738, "cf1.PaymentsToAcquireInvestments": -110644, "cf1.ProceedsOfInvestments": 0, "cf1.PaymentsToAcquirePropertyPlantAndEquipment": -20077, "cf1.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf1.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf1.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf1.ProceedsRelatedToInsuranceSettlement": 0, "cf1.ReveiptOfGovernmentGrants": 0, "cf1.PaymentOfLicenseFee": 0, "cf1.InvestingActivitiesInDiscontinuedOperations": 0, "cf1.OtherInvestingActivities": -113717, "cf1.FinanceLeasePrincipalPayments": 0, "cf1.ProceedsFromIssuanceOfCommonShares": 0, "cf1.ProceedsFromSharePurchasePlanAndOptionsExercice": 0, "cf1.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf1.PaymentsForRepurchaseOfCommonShares": 0, "cf1.PaymentsOfDividends": 0, "cf1.IncreaseDecreaseDeferredContingentConsideration": 0, "cf1.ProceedsFromIssuanceOfLongTermDebt": 278190, "cf1.RepaymentsOfLongTermDebt": 0, "cf1.FinancingCosts": 0, "cf1.NetChangeInShortTermBorrowings": 0, "cf1.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf1.NetChangeInNonControllingInterests": 0, "cf1.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf1.RepaymentsOfConvertible": 0, "cf1.IssuanceOfConvertible": 0, "cf1.EquityInvesteeAdvancesRepayments": 0, "cf1.OtherFinancingActivities": 4719313, "cf1.CashPaidForTaxes": 0, "cf1.CashPaidForInterest": 0, "cf2.AccessionNumber": "0001104659-20-029162", "cf2.AmendmentFlag": "", "cf2.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "cf2.Period": "secondlastyear", "cf2.PeriodEndDate": "2019-12-31", "cf2.TradingSymbol": "EYEG", "cf2.CashBeginningBalance": 8049237, "cf2.EffectOfExchangeRateOnCash": 5503, "cf2.DepreciationDepletionAndAmortization": 51672, "cf2.GainRelatedToDisposalOrSale": 0, "cf2.RestructuringAndOtherSpecialCharges": 0, "cf2.AccruedEmployeeCompensation": 0, "cf2.ShareBasedCompensation": 852230, "cf2.IncreaseDecreaseInIncomeTaxExpenseBenefit": 95396, "cf2.OtherNonCashIncomeExpense": 0, "cf2.IncreaseDecreaseInAccountsReceivable": 13210, "cf2.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": -3051, "cf2.IncreaseDecreaseInInventories": 0, "cf2.IncreaseDecreaseInOtherReceivables": 0, "cf2.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 157103, "cf2.IncreaseDecreaseInContractWithCustomerLiability": -2686000, "cf2.IncreaseDecreaseInRetirementBenefits": 0, "cf2.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf2.IncreaseDecreaseOperatingLeaseCurrent": -162261, "cf2.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf2.IncreaseDecreaseInOtherOperatingActivities": 624564, "cf2.PaymentsToAcquireInvestments": 0, "cf2.ProceedsOfInvestments": 0, "cf2.PaymentsToAcquirePropertyPlantAndEquipment": 0, "cf2.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf2.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf2.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf2.ProceedsRelatedToInsuranceSettlement": 0, "cf2.ReveiptOfGovernmentGrants": 0, "cf2.PaymentOfLicenseFee": 0, "cf2.InvestingActivitiesInDiscontinuedOperations": 0, "cf2.OtherInvestingActivities": 0, "cf2.FinanceLeasePrincipalPayments": 0, "cf2.ProceedsFromIssuanceOfCommonShares": 0, "cf2.ProceedsFromSharePurchasePlanAndOptionsExercice": 0, "cf2.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf2.PaymentsForRepurchaseOfCommonShares": 0, "cf2.PaymentsOfDividends": 0, "cf2.IncreaseDecreaseDeferredContingentConsideration": 0, "cf2.ProceedsFromIssuanceOfLongTermDebt": 0, "cf2.RepaymentsOfLongTermDebt": 0, "cf2.FinancingCosts": 0, "cf2.NetChangeInShortTermBorrowings": 0, "cf2.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf2.NetChangeInNonControllingInterests": 0, "cf2.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf2.RepaymentsOfConvertible": 0, "cf2.IssuanceOfConvertible": 0, "cf2.EquityInvesteeAdvancesRepayments": 0, "cf2.OtherFinancingActivities": 3920805, "cf2.CashPaidForTaxes": 0, "cf2.CashPaidForInterest": 0, "cf3.AccessionNumber": "0001144204-19-011634", "cf3.AmendmentFlag": "", "cf3.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "cf3.Period": "thirdlastyear", "cf3.PeriodEndDate": "2018-12-31", "cf3.TradingSymbol": "EYEG", "cf3.CashBeginningBalance": 7851029, "cf3.EffectOfExchangeRateOnCash": 7915, "cf3.DepreciationDepletionAndAmortization": 38483, "cf3.GainRelatedToDisposalOrSale": 0, "cf3.RestructuringAndOtherSpecialCharges": 0, "cf3.AccruedEmployeeCompensation": 0, "cf3.ShareBasedCompensation": 875287, "cf3.IncreaseDecreaseInIncomeTaxExpenseBenefit": 86045, "cf3.OtherNonCashIncomeExpense": 0, "cf3.IncreaseDecreaseInAccountsReceivable": 4191, "cf3.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": 379609, "cf3.IncreaseDecreaseInInventories": 0, "cf3.IncreaseDecreaseInOtherReceivables": 0, "cf3.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": -1336627, "cf3.IncreaseDecreaseInContractWithCustomerLiability": 540208, "cf3.IncreaseDecreaseInRetirementBenefits": 0, "cf3.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf3.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf3.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf3.IncreaseDecreaseInOtherOperatingActivities": -620285, "cf3.PaymentsToAcquireInvestments": 0, "cf3.ProceedsOfInvestments": 0, "cf3.PaymentsToAcquirePropertyPlantAndEquipment": -20000, "cf3.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf3.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf3.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf3.ProceedsRelatedToInsuranceSettlement": 0, "cf3.ReveiptOfGovernmentGrants": 0, "cf3.PaymentOfLicenseFee": 0, "cf3.InvestingActivitiesInDiscontinuedOperations": 0, "cf3.OtherInvestingActivities": -250000, "cf3.FinanceLeasePrincipalPayments": 0, "cf3.ProceedsFromIssuanceOfCommonShares": 10108762, "cf3.ProceedsFromSharePurchasePlanAndOptionsExercice": 0, "cf3.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf3.PaymentsForRepurchaseOfCommonShares": 0, "cf3.PaymentsOfDividends": 0, "cf3.IncreaseDecreaseDeferredContingentConsideration": 0, "cf3.ProceedsFromIssuanceOfLongTermDebt": 0, "cf3.RepaymentsOfLongTermDebt": 0, "cf3.FinancingCosts": 0, "cf3.NetChangeInShortTermBorrowings": 0, "cf3.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf3.NetChangeInNonControllingInterests": 0, "cf3.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf3.RepaymentsOfConvertible": 0, "cf3.IssuanceOfConvertible": 0, "cf3.EquityInvesteeAdvancesRepayments": 0, "cf3.OtherFinancingActivities": 1196043, "cf3.CashPaidForTaxes": 0, "cf3.CashPaidForInterest": 0, "cf4.AccessionNumber": "0001144204-18-012542", "cf4.AmendmentFlag": "", "cf4.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "cf4.Period": "fourthlastyear", "cf4.PeriodEndDate": "2017-12-31", "cf4.TradingSymbol": "EYEG", "cf4.CashBeginningBalance": 3680224, "cf4.EffectOfExchangeRateOnCash": 4992, "cf4.DepreciationDepletionAndAmortization": 19288, "cf4.GainRelatedToDisposalOrSale": 0, "cf4.RestructuringAndOtherSpecialCharges": 0, "cf4.AccruedEmployeeCompensation": 0, "cf4.ShareBasedCompensation": 870308, "cf4.IncreaseDecreaseInIncomeTaxExpenseBenefit": -1341973, "cf4.OtherNonCashIncomeExpense": 0, "cf4.IncreaseDecreaseInAccountsReceivable": 123496, "cf4.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": -447570, "cf4.IncreaseDecreaseInInventories": 0, "cf4.IncreaseDecreaseInOtherReceivables": 0, "cf4.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": -561691, "cf4.IncreaseDecreaseInContractWithCustomerLiability": 8088600, "cf4.IncreaseDecreaseInRetirementBenefits": 0, "cf4.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf4.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf4.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf4.IncreaseDecreaseInOtherOperatingActivities": -1082, "cf4.PaymentsToAcquireInvestments": 0, "cf4.ProceedsOfInvestments": 0, "cf4.PaymentsToAcquirePropertyPlantAndEquipment": -36999, "cf4.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf4.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf4.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf4.ProceedsRelatedToInsuranceSettlement": 0, "cf4.ReveiptOfGovernmentGrants": 0, "cf4.PaymentOfLicenseFee": 0, "cf4.InvestingActivitiesInDiscontinuedOperations": 0, "cf4.OtherInvestingActivities": 0, "cf4.FinanceLeasePrincipalPayments": 0, "cf4.ProceedsFromIssuanceOfCommonShares": 0, "cf4.ProceedsFromSharePurchasePlanAndOptionsExercice": 94815, "cf4.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf4.PaymentsForRepurchaseOfCommonShares": 0, "cf4.PaymentsOfDividends": 0, "cf4.IncreaseDecreaseDeferredContingentConsideration": 0, "cf4.ProceedsFromIssuanceOfLongTermDebt": 0, "cf4.RepaymentsOfLongTermDebt": 0, "cf4.FinancingCosts": 0, "cf4.NetChangeInShortTermBorrowings": 0, "cf4.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf4.NetChangeInNonControllingInterests": 0, "cf4.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf4.RepaymentsOfConvertible": 0, "cf4.IssuanceOfConvertible": 0, "cf4.EquityInvesteeAdvancesRepayments": 0, "cf4.OtherFinancingActivities": 10576538, "cf4.CashPaidForTaxes": 0, "cf4.CashPaidForInterest": 0, "cf5.AccessionNumber": "0001144204-17-010635", "cf5.AmendmentFlag": "", "cf5.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "cf5.Period": "fifthlastyear", "cf5.PeriodEndDate": "2016-12-31", "cf5.TradingSymbol": "EYEG", "cf5.CashBeginningBalance": 8394133, "cf5.EffectOfExchangeRateOnCash": 6298, "cf5.DepreciationDepletionAndAmortization": 5185, "cf5.GainRelatedToDisposalOrSale": 0, "cf5.RestructuringAndOtherSpecialCharges": 0, "cf5.AccruedEmployeeCompensation": 0, "cf5.ShareBasedCompensation": 510995, "cf5.IncreaseDecreaseInIncomeTaxExpenseBenefit": 0, "cf5.OtherNonCashIncomeExpense": 0, "cf5.IncreaseDecreaseInAccountsReceivable": 3241339, "cf5.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": 26287, "cf5.IncreaseDecreaseInInventories": 0, "cf5.IncreaseDecreaseInOtherReceivables": 0, "cf5.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 1163178, "cf5.IncreaseDecreaseInContractWithCustomerLiability": 0, "cf5.IncreaseDecreaseInRetirementBenefits": 0, "cf5.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf5.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf5.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf5.IncreaseDecreaseInOtherOperatingActivities": -16727, "cf5.PaymentsToAcquireInvestments": 185746, "cf5.ProceedsOfInvestments": 0, "cf5.PaymentsToAcquirePropertyPlantAndEquipment": -11000, "cf5.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf5.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf5.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf5.ProceedsRelatedToInsuranceSettlement": 0, "cf5.ReveiptOfGovernmentGrants": 0, "cf5.PaymentOfLicenseFee": 0, "cf5.InvestingActivitiesInDiscontinuedOperations": 0, "cf5.OtherInvestingActivities": -25000, "cf5.FinanceLeasePrincipalPayments": 0, "cf5.ProceedsFromIssuanceOfCommonShares": 3444884, "cf5.ProceedsFromSharePurchasePlanAndOptionsExercice": 56206, "cf5.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf5.PaymentsForRepurchaseOfCommonShares": 0, "cf5.PaymentsOfDividends": 0, "cf5.IncreaseDecreaseDeferredContingentConsideration": 0, "cf5.ProceedsFromIssuanceOfLongTermDebt": 0, "cf5.RepaymentsOfLongTermDebt": 0, "cf5.FinancingCosts": 0, "cf5.NetChangeInShortTermBorrowings": 0, "cf5.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf5.NetChangeInNonControllingInterests": 0, "cf5.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf5.RepaymentsOfConvertible": 0, "cf5.IssuanceOfConvertible": 0, "cf5.EquityInvesteeAdvancesRepayments": 0, "cf5.OtherFinancingActivities": -2863, "cf5.CashPaidForTaxes": 0, "cf5.CashPaidForInterest": 0, "cf6.AccessionNumber": "0001144204-16-091485", "cf6.AmendmentFlag": "", "cf6.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "cf6.Period": "sixthlastyear", "cf6.PeriodEndDate": "2015-12-31", "cf6.TradingSymbol": "EYEG", "cf6.CashBeginningBalance": 167001, "cf6.EffectOfExchangeRateOnCash": 90045, "cf6.DepreciationDepletionAndAmortization": 1257, "cf6.GainRelatedToDisposalOrSale": 0, "cf6.RestructuringAndOtherSpecialCharges": 244111, "cf6.AccruedEmployeeCompensation": 0, "cf6.ShareBasedCompensation": 1224687, "cf6.IncreaseDecreaseInIncomeTaxExpenseBenefit": 0, "cf6.OtherNonCashIncomeExpense": 1663873, "cf6.IncreaseDecreaseInAccountsReceivable": -909857, "cf6.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": -95952, "cf6.IncreaseDecreaseInInventories": 0, "cf6.IncreaseDecreaseInOtherReceivables": 0, "cf6.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 117504, "cf6.IncreaseDecreaseInContractWithCustomerLiability": 1907500, "cf6.IncreaseDecreaseInRetirementBenefits": 0, "cf6.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf6.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf6.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf6.IncreaseDecreaseInOtherOperatingActivities": -224320, "cf6.PaymentsToAcquireInvestments": 0, "cf6.ProceedsOfInvestments": 0, "cf6.PaymentsToAcquirePropertyPlantAndEquipment": 0, "cf6.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf6.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf6.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf6.ProceedsRelatedToInsuranceSettlement": 0, "cf6.ReveiptOfGovernmentGrants": 0, "cf6.PaymentOfLicenseFee": 0, "cf6.InvestingActivitiesInDiscontinuedOperations": 0, "cf6.OtherInvestingActivities": -20000, "cf6.FinanceLeasePrincipalPayments": 0, "cf6.ProceedsFromIssuanceOfCommonShares": 12622058, "cf6.ProceedsFromSharePurchasePlanAndOptionsExercice": 26826, "cf6.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf6.PaymentsForRepurchaseOfCommonShares": 0, "cf6.PaymentsOfDividends": 0, "cf6.IncreaseDecreaseDeferredContingentConsideration": 0, "cf6.ProceedsFromIssuanceOfLongTermDebt": 0, "cf6.RepaymentsOfLongTermDebt": 0, "cf6.FinancingCosts": 0, "cf6.NetChangeInShortTermBorrowings": 0, "cf6.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf6.NetChangeInNonControllingInterests": 0, "cf6.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf6.RepaymentsOfConvertible": 0, "cf6.IssuanceOfConvertible": 0, "cf6.EquityInvesteeAdvancesRepayments": 0, "cf6.OtherFinancingActivities": -32628, "cf6.CashPaidForTaxes": 0, "cf6.CashPaidForInterest": 0, "tb1.AccessionNumber": "0001104659-21-041515", "tb1.AmendmentFlag": "", "tb1.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "tb1.Link": "0", "tb1.Period": "lastyear", "tb1.PeriodEndDate": "2020-12-31", "tb1.PeriodOfReport": "0", "tb1.TradingSymbol": "EYEG", "tb1.Cash": 1185677, "tb1.ShortTermInvestments": 0, "tb1.AccountsReceivable": 90975, "tb1.WorkInProgress": 0, "tb1.Inventories": 0, "tb1.PrepaidExpenses": 449569, "tb1.NonTradeReceivables": 0, "tb1.PrepaidTaxAssetsCurrent": 0, "tb1.DeferredTaxAssetsCurrent": 0, "tb1.RightOfUseAssetsCurrent": 83928, "tb1.OtherCurrentAssets": 0, "tb1.DiscontinuedOperationsCurrent": 0, "tb1.LongTermReceivables": 0, "tb1.DeferredCharges": 0, "tb1.Investments": 0, "tb1.PropertyPlantAndEquipment": 30566, "tb1.OperatingLeaseRightOfUseAssets": 0, "tb1.FinanceLeaseRightOfUseAssets": 0, "tb1.IntangibleAssets": 9730164, "tb1.Goodwill": 3484607, "tb1.RefundableTaxAssetsNonCurrent": 0, "tb1.DeferredTaxAssetsNonCurrent": 0, "tb1.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb1.OtherNonCurrentAssets": 102073, "tb1.DiscontinuedOperations": 0, "tb1.AccountsPayableAndAccruedLiabilities": -1724024, "tb1.EmployeeCompensationCurrent": 0, "tb1.OperatingLeasesCurrent": -35625, "tb1.FinanceLeasesCurrent": 0, "tb1.DeferredRevenueAndDepositsCurrent": 0, "tb1.AccruedTaxLiabilities": 0, "tb1.DeferredTaxLiabilitiesCurrent": 0, "tb1.CommercialPapers": 0, "tb1.ShortTermBorrowings": 0, "tb1.OtherCurrentLiabilities": -12678, "tb1.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb1.DividendsPayable": 0, "tb1.ShortTermPortionOfLongTermDebt": 0, "tb1.LongTermDebt": -278190, "tb1.PreferredSharesLiability": 0, "tb1.RetirementBenefits": 0, "tb1.OperatingLeasesNonCurrent": 0, "tb1.FinanceLeasesNonCurrent": 0, "tb1.LeaseIncentiveObligation": 0, "tb1.DeferredRevenueAndDepositsNonCurrent": 0, "tb1.ContingentConsideration": -5342950, "tb1.AccruedTaxLiabilitiesNonCurrent": 0, "tb1.DeferredTaxLiabilitiesNonCurrent": -728926, "tb1.OtherNonCurrentLiabilities": -35625, "tb1.RedeemableNonControllingInterests": 0, "tb1.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb1.ConvertibleDebtBeginning": 0, "tb1.CommonSharesBeginning": -106729843, "tb1.CommonSharesIssued": -4501313, "tb1.ShareBasedCompensation": -4107980, "tb1.PreferredSharesBeginning": 0, "tb1.RetainedEarningsBeginning": 100246894, "tb1.DividendsAndDividendEquivalentsDeclared": 0, "tb1.CommonSharesRepurchasedAndRetired": 0, "tb1.ShareBasedCompensationRetainedEarnings": 0, "tb1.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb1.RetainedEarningsOthers": 0, "tb1.AccumulatedOtherComprehensiveIncomeBeginning": -139465, "tb1.TreasurySharesBeginning": 0, "tb1.PurchaseAndSellOfTreasuryShares": 0, "tb1.EmployeeBenefitTrustBeginning": 0, "tb1.NonControllingInterestsBeginning": 0, "tb1.DividendsDeclaredToNonControllingInterests": 0, "tb1.AcquisitionOfNonControllingInterests": 0, "tb1.NonControllingInterestsOthers": 0, "tb1.Sales": -12059, "tb1.CostOfSales": 0, "tb1.ResearchAndDevelopment": 3566045, "tb1.SellingGeneralAdministrativeAndMarketing": 4658769, "tb1.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb1.NonOperatingIncome": -132870, "tb1.IncomeTaxExpenseBenefit": 12055, "tb1.EquityMethodInvesteesIncome": 0, "tb1.NetIncomeFromDiscontinuedOperations": 0, "tb1.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb1.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb1.ChangeInUnrealizedGainsLossesOnInvestments": 140267, "tb1.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb1.IncomeTaxOnOtherComprehensiveIncome": 0, "tb2.AccessionNumber": "0001104659-20-029162", "tb2.AmendmentFlag": "", "tb2.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "tb2.Link": "0", "tb2.Period": "secondlastyear", "tb2.PeriodEndDate": "2019-12-31", "tb2.PeriodOfReport": "0", "tb2.TradingSymbol": "EYEG", "tb2.Cash": 3776712, "tb2.ShortTermInvestments": 0, "tb2.AccountsReceivable": 4857, "tb2.WorkInProgress": 0, "tb2.Inventories": 0, "tb2.PrepaidExpenses": 458810, "tb2.NonTradeReceivables": 0, "tb2.PrepaidTaxAssetsCurrent": 0, "tb2.DeferredTaxAssetsCurrent": 0, "tb2.RightOfUseAssetsCurrent": 83926, "tb2.OtherCurrentAssets": 0, "tb2.DiscontinuedOperationsCurrent": 0, "tb2.LongTermReceivables": 0, "tb2.DeferredCharges": 0, "tb2.Investments": 0, "tb2.PropertyPlantAndEquipment": 16846, "tb2.OperatingLeaseRightOfUseAssets": 0, "tb2.FinanceLeaseRightOfUseAssets": 0, "tb2.IntangibleAssets": 4131064, "tb2.Goodwill": 1525896, "tb2.RefundableTaxAssetsNonCurrent": 0, "tb2.DeferredTaxAssetsNonCurrent": 0, "tb2.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb2.OtherNonCurrentAssets": 114403, "tb2.DiscontinuedOperations": 0, "tb2.AccountsPayableAndAccruedLiabilities": -1330769, "tb2.EmployeeCompensationCurrent": 0, "tb2.OperatingLeasesCurrent": -83926, "tb2.FinanceLeasesCurrent": 0, "tb2.DeferredRevenueAndDepositsCurrent": 0, "tb2.AccruedTaxLiabilities": 0, "tb2.DeferredTaxLiabilitiesCurrent": 0, "tb2.CommercialPapers": 0, "tb2.ShortTermBorrowings": 0, "tb2.OtherCurrentLiabilities": 0, "tb2.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb2.DividendsPayable": 0, "tb2.ShortTermPortionOfLongTermDebt": 0, "tb2.LongTermDebt": 0, "tb2.PreferredSharesLiability": 0, "tb2.RetirementBenefits": 0, "tb2.OperatingLeasesNonCurrent": 0, "tb2.FinanceLeasesNonCurrent": 0, "tb2.LeaseIncentiveObligation": 0, "tb2.DeferredRevenueAndDepositsNonCurrent": 0, "tb2.ContingentConsideration": -1710000, "tb2.AccruedTaxLiabilitiesNonCurrent": 0, "tb2.DeferredTaxLiabilitiesNonCurrent": -365364, "tb2.OtherNonCurrentLiabilities": 0, "tb2.RedeemableNonControllingInterests": 0, "tb2.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb2.ConvertibleDebtBeginning": 0, "tb2.CommonSharesBeginning": -101952093, "tb2.CommonSharesIssued": 0, "tb2.ShareBasedCompensation": -4777750, "tb2.PreferredSharesBeginning": 0, "tb2.RetainedEarningsBeginning": 93150198, "tb2.DividendsAndDividendEquivalentsDeclared": 0, "tb2.CommonSharesRepurchasedAndRetired": 0, "tb2.ShareBasedCompensationRetainedEarnings": 0, "tb2.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb2.RetainedEarningsOthers": 0, "tb2.AccumulatedOtherComprehensiveIncomeBeginning": -134331, "tb2.TreasurySharesBeginning": 0, "tb2.PurchaseAndSellOfTreasuryShares": 0, "tb2.EmployeeBenefitTrustBeginning": 0, "tb2.NonControllingInterestsBeginning": 0, "tb2.DividendsDeclaredToNonControllingInterests": 0, "tb2.AcquisitionOfNonControllingInterests": 0, "tb2.NonControllingInterestsOthers": 0, "tb2.Sales": -2686000, "tb2.CostOfSales": 0, "tb2.ResearchAndDevelopment": -5389357, "tb2.SellingGeneralAdministrativeAndMarketing": 4405684, "tb2.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb2.NonOperatingIncome": 10670973, "tb2.IncomeTaxExpenseBenefit": 95396, "tb2.EquityMethodInvesteesIncome": 0, "tb2.NetIncomeFromDiscontinuedOperations": 0, "tb2.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb2.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb2.ChangeInUnrealizedGainsLossesOnInvestments": -5134, "tb2.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb2.IncomeTaxOnOtherComprehensiveIncome": 0, "tb3.AccessionNumber": "0001144204-19-011634", "tb3.AmendmentFlag": "", "tb3.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "tb3.Link": "0", "tb3.Period": "thirdlastyear", "tb3.PeriodEndDate": "2018-12-31", "tb3.PeriodOfReport": "0", "tb3.TradingSymbol": "EYEG", "tb3.Cash": 8004237, "tb3.ShortTermInvestments": 0, "tb3.AccountsReceivable": 18436, "tb3.WorkInProgress": 0, "tb3.Inventories": 0, "tb3.PrepaidExpenses": 455760, "tb3.NonTradeReceivables": 0, "tb3.PrepaidTaxAssetsCurrent": 0, "tb3.DeferredTaxAssetsCurrent": 0, "tb3.RightOfUseAssetsCurrent": 0, "tb3.OtherCurrentAssets": 0, "tb3.DiscontinuedOperationsCurrent": 0, "tb3.LongTermReceivables": 0, "tb3.DeferredCharges": 0, "tb3.Investments": 0, "tb3.PropertyPlantAndEquipment": 43518, "tb3.OperatingLeaseRightOfUseAssets": 0, "tb3.FinanceLeaseRightOfUseAssets": 0, "tb3.IntangibleAssets": 4156064, "tb3.Goodwill": 1525896, "tb3.RefundableTaxAssetsNonCurrent": 0, "tb3.DeferredTaxAssetsNonCurrent": 0, "tb3.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb3.OtherNonCurrentAssets": 76706, "tb3.DiscontinuedOperations": 0, "tb3.AccountsPayableAndAccruedLiabilities": -1178382, "tb3.EmployeeCompensationCurrent": 0, "tb3.OperatingLeasesCurrent": 0, "tb3.FinanceLeasesCurrent": 0, "tb3.DeferredRevenueAndDepositsCurrent": -2686000, "tb3.AccruedTaxLiabilities": 0, "tb3.DeferredTaxLiabilitiesCurrent": 0, "tb3.CommercialPapers": 0, "tb3.ShortTermBorrowings": 0, "tb3.OtherCurrentLiabilities": 0, "tb3.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb3.DividendsPayable": 0, "tb3.ShortTermPortionOfLongTermDebt": 0, "tb3.LongTermDebt": 0, "tb3.PreferredSharesLiability": 0, "tb3.RetirementBenefits": 0, "tb3.OperatingLeasesNonCurrent": 0, "tb3.FinanceLeasesNonCurrent": 0, "tb3.LeaseIncentiveObligation": 0, "tb3.DeferredRevenueAndDepositsNonCurrent": 0, "tb3.ContingentConsideration": -1210000, "tb3.AccruedTaxLiabilitiesNonCurrent": 0, "tb3.DeferredTaxLiabilitiesNonCurrent": -269968, "tb3.OtherNonCurrentLiabilities": 0, "tb3.RedeemableNonControllingInterests": 0, "tb3.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb3.ConvertibleDebtBeginning": 0, "tb3.CommonSharesBeginning": -89762254, "tb3.CommonSharesIssued": -11368619, "tb3.ShareBasedCompensation": -821220, "tb3.PreferredSharesBeginning": 0, "tb3.RetainedEarningsBeginning": 91816655, "tb3.DividendsAndDividendEquivalentsDeclared": 0, "tb3.CommonSharesRepurchasedAndRetired": 0, "tb3.ShareBasedCompensationRetainedEarnings": 0, "tb3.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 9477880, "tb3.RetainedEarningsOthers": -18955760, "tb3.AccumulatedOtherComprehensiveIncomeBeginning": -127473, "tb3.TreasurySharesBeginning": 0, "tb3.PurchaseAndSellOfTreasuryShares": 0, "tb3.EmployeeBenefitTrustBeginning": 0, "tb3.NonControllingInterestsBeginning": 0, "tb3.DividendsDeclaredToNonControllingInterests": 0, "tb3.AcquisitionOfNonControllingInterests": 0, "tb3.NonControllingInterestsOthers": 0, "tb3.Sales": -1652520, "tb3.CostOfSales": 0, "tb3.ResearchAndDevelopment": 8055763, "tb3.SellingGeneralAdministrativeAndMarketing": 4441458, "tb3.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb3.NonOperatingIncome": -119323, "tb3.IncomeTaxExpenseBenefit": 86045, "tb3.EquityMethodInvesteesIncome": 0, "tb3.NetIncomeFromDiscontinuedOperations": 0, "tb3.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb3.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb3.ChangeInUnrealizedGainsLossesOnInvestments": -6858, "tb3.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb3.IncomeTaxOnOtherComprehensiveIncome": 0, "tb4.AccessionNumber": "0001144204-18-012542", "tb4.AmendmentFlag": "", "tb4.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "tb4.Link": "0", "tb4.Period": "fourthlastyear", "tb4.PeriodEndDate": "2017-12-31", "tb4.PeriodOfReport": "0", "tb4.TradingSymbol": "EYEG", "tb4.Cash": 7806029, "tb4.ShortTermInvestments": 0, "tb4.AccountsReceivable": 23685, "tb4.WorkInProgress": 0, "tb4.Inventories": 0, "tb4.PrepaidExpenses": 629591, "tb4.NonTradeReceivables": 0, "tb4.PrepaidTaxAssetsCurrent": 0, "tb4.DeferredTaxAssetsCurrent": 0, "tb4.RightOfUseAssetsCurrent": 0, "tb4.OtherCurrentAssets": 0, "tb4.DiscontinuedOperationsCurrent": 0, "tb4.LongTermReceivables": 0, "tb4.DeferredCharges": 0, "tb4.Investments": 0, "tb4.PropertyPlantAndEquipment": 55751, "tb4.OperatingLeaseRightOfUseAssets": 0, "tb4.FinanceLeaseRightOfUseAssets": 0, "tb4.IntangibleAssets": 0, "tb4.Goodwill": 5438210, "tb4.RefundableTaxAssetsNonCurrent": 0, "tb4.DeferredTaxAssetsNonCurrent": 0, "tb4.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb4.OtherNonCurrentAssets": 352126, "tb4.DiscontinuedOperations": 0, "tb4.AccountsPayableAndAccruedLiabilities": -2519936, "tb4.EmployeeCompensationCurrent": 0, "tb4.OperatingLeasesCurrent": 0, "tb4.FinanceLeasesCurrent": 0, "tb4.DeferredRevenueAndDepositsCurrent": -12313600, "tb4.AccruedTaxLiabilities": 0, "tb4.DeferredTaxLiabilitiesCurrent": 0, "tb4.CommercialPapers": 0, "tb4.ShortTermBorrowings": 0, "tb4.OtherCurrentLiabilities": 0, "tb4.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb4.DividendsPayable": 0, "tb4.ShortTermPortionOfLongTermDebt": 0, "tb4.LongTermDebt": 0, "tb4.PreferredSharesLiability": 0, "tb4.RetirementBenefits": 0, "tb4.OperatingLeasesNonCurrent": 0, "tb4.FinanceLeasesNonCurrent": -4855, "tb4.LeaseIncentiveObligation": 0, "tb4.DeferredRevenueAndDepositsNonCurrent": 0, "tb4.ContingentConsideration": -1210000, "tb4.AccruedTaxLiabilitiesNonCurrent": 0, "tb4.DeferredTaxLiabilitiesNonCurrent": -183923, "tb4.OtherNonCurrentLiabilities": 0, "tb4.RedeemableNonControllingInterests": 0, "tb4.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb4.ConvertibleDebtBeginning": 0, "tb4.CommonSharesBeginning": -78207954, "tb4.CommonSharesIssued": -8665780, "tb4.ShareBasedCompensation": -2888520, "tb4.PreferredSharesBeginning": 0, "tb4.RetainedEarningsBeginning": 78598738, "tb4.DividendsAndDividendEquivalentsDeclared": 0, "tb4.CommonSharesRepurchasedAndRetired": 0, "tb4.ShareBasedCompensationRetainedEarnings": 0, "tb4.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb4.RetainedEarningsOthers": 0, "tb4.AccumulatedOtherComprehensiveIncomeBeginning": -120187, "tb4.TreasurySharesBeginning": 0, "tb4.PurchaseAndSellOfTreasuryShares": 0, "tb4.EmployeeBenefitTrustBeginning": 0, "tb4.NonControllingInterestsBeginning": 0, "tb4.DividendsDeclaredToNonControllingInterests": 0, "tb4.AcquisitionOfNonControllingInterests": 0, "tb4.NonControllingInterestsOthers": 0, "tb4.Sales": -407518, "tb4.CostOfSales": 0, "tb4.ResearchAndDevelopment": 10330349, "tb4.SellingGeneralAdministrativeAndMarketing": 4636408, "tb4.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb4.NonOperatingIncome": 651, "tb4.IncomeTaxExpenseBenefit": -1341973, "tb4.EquityMethodInvesteesIncome": 0, "tb4.NetIncomeFromDiscontinuedOperations": 0, "tb4.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb4.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb4.ChangeInUnrealizedGainsLossesOnInvestments": -7286, "tb4.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb4.IncomeTaxOnOtherComprehensiveIncome": 0, "tb5.AccessionNumber": "0001144204-17-010635", "tb5.AmendmentFlag": "", "tb5.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "tb5.Link": "0", "tb5.Period": "fifthlastyear", "tb5.PeriodEndDate": "2016-12-31", "tb5.PeriodOfReport": "0", "tb5.TradingSymbol": "EYEG", "tb5.Cash": 3635224, "tb5.ShortTermInvestments": 0, "tb5.AccountsReceivable": 53833, "tb5.WorkInProgress": 0, "tb5.Inventories": 0, "tb5.PrepaidExpenses": 464981, "tb5.NonTradeReceivables": 0, "tb5.PrepaidTaxAssetsCurrent": 0, "tb5.DeferredTaxAssetsCurrent": 0, "tb5.RightOfUseAssetsCurrent": 0, "tb5.OtherCurrentAssets": 0, "tb5.DiscontinuedOperationsCurrent": 0, "tb5.LongTermReceivables": 0, "tb5.DeferredCharges": 0, "tb5.Investments": 0, "tb5.PropertyPlantAndEquipment": 38040, "tb5.OperatingLeaseRightOfUseAssets": 0, "tb5.FinanceLeaseRightOfUseAssets": 0, "tb5.IntangibleAssets": 0, "tb5.Goodwill": 5438210, "tb5.RefundableTaxAssetsNonCurrent": 0, "tb5.DeferredTaxAssetsNonCurrent": 0, "tb5.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb5.OtherNonCurrentAssets": 100314, "tb5.DiscontinuedOperations": 0, "tb5.AccountsPayableAndAccruedLiabilities": -3083058, "tb5.EmployeeCompensationCurrent": 0, "tb5.OperatingLeasesCurrent": 0, "tb5.FinanceLeasesCurrent": 0, "tb5.DeferredRevenueAndDepositsCurrent": -4225000, "tb5.AccruedTaxLiabilities": 0, "tb5.DeferredTaxLiabilitiesCurrent": 0, "tb5.CommercialPapers": 0, "tb5.ShortTermBorrowings": 0, "tb5.OtherCurrentLiabilities": 0, "tb5.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb5.DividendsPayable": 0, "tb5.ShortTermPortionOfLongTermDebt": 0, "tb5.LongTermDebt": 0, "tb5.PreferredSharesLiability": 0, "tb5.RetirementBenefits": 0, "tb5.OperatingLeasesNonCurrent": 0, "tb5.FinanceLeasesNonCurrent": -16069, "tb5.LeaseIncentiveObligation": 0, "tb5.DeferredRevenueAndDepositsNonCurrent": 0, "tb5.ContingentConsideration": -1210000, "tb5.AccruedTaxLiabilitiesNonCurrent": 0, "tb5.DeferredTaxLiabilitiesNonCurrent": -1525896, "tb5.OtherNonCurrentLiabilities": 0, "tb5.RedeemableNonControllingInterests": 0, "tb5.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb5.ConvertibleDebtBeginning": 0, "tb5.CommonSharesBeginning": -77539517, "tb5.CommonSharesIssued": -668437, "tb5.ShareBasedCompensation": 0, "tb5.PreferredSharesBeginning": 0, "tb5.RetainedEarningsBeginning": 65255301, "tb5.DividendsAndDividendEquivalentsDeclared": 0, "tb5.CommonSharesRepurchasedAndRetired": 0, "tb5.ShareBasedCompensationRetainedEarnings": 0, "tb5.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb5.RetainedEarningsOthers": 0, "tb5.AccumulatedOtherComprehensiveIncomeBeginning": -120187, "tb5.TreasurySharesBeginning": 0, "tb5.PurchaseAndSellOfTreasuryShares": 0, "tb5.EmployeeBenefitTrustBeginning": 0, "tb5.NonControllingInterestsBeginning": 0, "tb5.DividendsDeclaredToNonControllingInterests": 0, "tb5.AcquisitionOfNonControllingInterests": 0, "tb5.NonControllingInterestsOthers": 0, "tb5.Sales": -669259, "tb5.CostOfSales": 669259, "tb5.ResearchAndDevelopment": 0, "tb5.SellingGeneralAdministrativeAndMarketing": 0, "tb5.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb5.NonOperatingIncome": 0, "tb5.IncomeTaxExpenseBenefit": 0, "tb5.EquityMethodInvesteesIncome": 0, "tb5.NetIncomeFromDiscontinuedOperations": 0, "tb5.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb5.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb5.ChangeInUnrealizedGainsLossesOnInvestments": 0, "tb5.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb5.IncomeTaxOnOtherComprehensiveIncome": 0, "tb6.AccessionNumber": "0001144204-16-091485", "tb6.AmendmentFlag": "", "tb6.EntityRegistrantName": "EYEGATE PHARMACEUTICALS INC", "tb6.Link": "0", "tb6.Period": "sixthlastyear", "tb6.PeriodEndDate": "2015-12-31", "tb6.PeriodOfReport": "0", "tb6.TradingSymbol": "EYEG", "tb6.Cash": 8394133, "tb6.ShortTermInvestments": 0, "tb6.AccountsReceivable": 932586, "tb6.WorkInProgress": 0, "tb6.Inventories": 0, "tb6.PrepaidExpenses": 122395, "tb6.NonTradeReceivables": 0, "tb6.PrepaidTaxAssetsCurrent": 0, "tb6.DeferredTaxAssetsCurrent": 0, "tb6.RightOfUseAssetsCurrent": 0, "tb6.OtherCurrentAssets": 0, "tb6.DiscontinuedOperationsCurrent": 0, "tb6.LongTermReceivables": 0, "tb6.DeferredCharges": 0, "tb6.Investments": 0, "tb6.PropertyPlantAndEquipment": 0, "tb6.OperatingLeaseRightOfUseAssets": 0, "tb6.FinanceLeaseRightOfUseAssets": 0, "tb6.IntangibleAssets": 0, "tb6.Goodwill": 0, "tb6.RefundableTaxAssetsNonCurrent": 0, "tb6.DeferredTaxAssetsNonCurrent": 0, "tb6.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb6.OtherNonCurrentAssets": 58587, "tb6.DiscontinuedOperations": 0, "tb6.AccountsPayableAndAccruedLiabilities": -1513435, "tb6.EmployeeCompensationCurrent": 0, "tb6.OperatingLeasesCurrent": 0, "tb6.FinanceLeasesCurrent": 0, "tb6.DeferredRevenueAndDepositsCurrent": -1907500, "tb6.AccruedTaxLiabilities": 0, "tb6.DeferredTaxLiabilitiesCurrent": 0, "tb6.CommercialPapers": 0, "tb6.ShortTermBorrowings": 0, "tb6.OtherCurrentLiabilities": 0, "tb6.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb6.DividendsPayable": 0, "tb6.ShortTermPortionOfLongTermDebt": 0, "tb6.LongTermDebt": 0, "tb6.PreferredSharesLiability": 0, "tb6.RetirementBenefits": 0, "tb6.OperatingLeasesNonCurrent": 0, "tb6.FinanceLeasesNonCurrent": 0, "tb6.LeaseIncentiveObligation": 0, "tb6.DeferredRevenueAndDepositsNonCurrent": 0, "tb6.ContingentConsideration": 0, "tb6.AccruedTaxLiabilitiesNonCurrent": 0, "tb6.DeferredTaxLiabilitiesNonCurrent": 0, "tb6.OtherNonCurrentLiabilities": 9507701, "tb6.RedeemableNonControllingInterests": 0, "tb6.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb6.ConvertibleDebtBeginning": 0, "tb6.CommonSharesBeginning": 14082662, "tb6.CommonSharesIssued": -14082662, "tb6.ShareBasedCompensation": 0, "tb6.PreferredSharesBeginning": 0, "tb6.RetainedEarningsBeginning": -8387972, "tb6.DividendsAndDividendEquivalentsDeclared": 0, "tb6.CommonSharesRepurchasedAndRetired": 0, "tb6.ShareBasedCompensationRetainedEarnings": 0, "tb6.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb6.RetainedEarningsOthers": 0, "tb6.AccumulatedOtherComprehensiveIncomeBeginning": -23577, "tb6.TreasurySharesBeginning": 0, "tb6.PurchaseAndSellOfTreasuryShares": 0, "tb6.EmployeeBenefitTrustBeginning": 0, "tb6.NonControllingInterestsBeginning": 0, "tb6.DividendsDeclaredToNonControllingInterests": 0, "tb6.AcquisitionOfNonControllingInterests": 0, "tb6.NonControllingInterestsOthers": 0, "tb6.Sales": 0, "tb6.CostOfSales": 0, "tb6.ResearchAndDevelopment": 0, "tb6.SellingGeneralAdministrativeAndMarketing": 0, "tb6.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb6.NonOperatingIncome": 0, "tb6.IncomeTaxExpenseBenefit": 0, "tb6.EquityMethodInvesteesIncome": 0, "tb6.NetIncomeFromDiscontinuedOperations": 0, "tb6.ChangeInForeignCurrencyTranslationAdjustment": -91211, "tb6.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb6.ChangeInUnrealizedGainsLossesOnInvestments": 0, "tb6.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb6.IncomeTaxOnOtherComprehensiveIncome": 0}]}